Jounce Therapeutics, Inc. Share Price
Equities
JNCE
US4811161011
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 31/08/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 18 M€ | +2.76% | - |
1st Jan change | Capi. | |
---|---|---|
-2.28% | 103B | |
+1.86% | 95.28B | |
+1.46% | 22.15B | |
-15.64% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.30% | 16.05B | |
+4.94% | 13.68B | |
+35.67% | 12.17B |